Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lexi Wu"'
Publikováno v:
Laparoscopic, Endoscopic and Robotic Surgery, Vol 4, Iss 2, Pp 33-39 (2021)
Objective: The ulcerative colitis endoscopic index of severity (UCEIS) and the Mayo endoscopic score (MES) are developed as objective methods of evaluating endoscopic severity in patients with ulcerative colitis (UC). The aim of this study is to inve
Externí odkaz:
https://doaj.org/article/c7ad1721603541c3a6a44f3f89f7db80
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background and Aims: Ustekinumab (UST) was approved in China for treating moderate-to-severe Crohn’s disease (CD) in 2020. We aimed to identify the reasons and possible contributing factors for UST preference in Chinese patients with CD.Methods: We
Externí odkaz:
https://doaj.org/article/e2a228815b4e48f8bbc0dae0ec89d22a
Publikováno v:
IEEE transactions on biomedical circuits and systems. 16(5)
Currently, there is no suitable solution for the point-of-care diagnosis of knee injuries. A potential portable and low-cost technique for accessing and monitoring knee injuries is bioimpedance measurement. This study validated the feasibility of the
Currently, there is no suitable solution for the point-of-care of knee injuries. A potential portable and low-cost technique for accessing and monitoring knee injuries is bioimpedance measurement. This study validated the feasibility of the bipolar e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c4a1d14100a3dcde1725974b5a15512
https://doi.org/10.21203/rs.3.rs-690831/v1
https://doi.org/10.21203/rs.3.rs-690831/v1
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Background and Aims: Ustekinumab (UST) was approved in China for treating moderate-to-severe Crohn’s disease (CD) in 2020. We aimed to identify the reasons and possible contributing factors for UST preference in Chinese patients with CD.Methods: We
Publikováno v:
Journal of Crohn's and Colitis. 15:S524-S525
Background The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) and the Mayo Endoscopic Score (MES) were developed as an objective method of the endoscopic severity in ulcerative colitis (UC); however, it was still unclear whether UCEIS and ME